Skip to main content
Fig. 7 | BMC Pharmacology and Toxicology

Fig. 7

From: Analysis of lung cancer-related genetic changes in long-term and low-dose polyhexamethylene guanidine phosphate (PHMG-p) treated human pulmonary alveolar epithelial cells

Fig. 7

Clinical significance of selected genes in patients with lung adenocarcinoma. Kaplan–Meier survival analysis generated for groups of patients based on the expression levels of upregulated genes (ISG15, MMP1, TRPA1 and KRT19) (a) and downregulated genes (FMO3, COL14A1, FMO2 and TIMP3) (b) in the database

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us